Warren Buffett It takes just a few winners to work wonders - TKer by Sam Ro
| 009300 Stock | KRW 17,310 240.00 1.37% |
About 61% of Sam A's investor base is looking to short. The analysis of current outlook of investing in Sam A Pharm Co suggests that many traders are alarmed regarding Sam A's prospects. The current market sentiment, together with Sam A's historical and current headlines, can help investors time the market. In addition, many technical investors use Sam A Pharm stock news signals to limit their universe of possible portfolio assets.
Sam |
Warren Buffett It takes just a few winners to work wonders TKer by Sam Ro
Read at news.google.com
 |
Sam A Fundamental Analysis
We analyze Sam A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sam A using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sam A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Sam A is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Sam A Pharm Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sam A stock to make a market-neutral strategy. Peer analysis of Sam A could also be used in its relative valuation, which is a method of valuing Sam A by comparing valuation metrics with similar companies.
Peers
Sam A Related Equities
| 065660 | AnterogenCoLtd | 8.86 | ||||
| 102940 | Kolon Life | 3.23 | ||||
| 023910 | Daihan Pharmaceutical | 2.25 | ||||
| 074430 | Aminologics CoLtd | 1.19 | ||||
| 106190 | High Tech | 0.42 | ||||
| 330350 | Withuspharmaceutical | 1.19 | ||||
| 047920 | HLB Pharmaceutical | 1.75 | ||||
| 216080 | JETEMA | 2.20 |
Complementary Tools for Sam Stock analysis
When running Sam A's price analysis, check to measure Sam A's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sam A is operating at the current time. Most of Sam A's value examination focuses on studying past and present price action to predict the probability of Sam A's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sam A's price. Additionally, you may evaluate how the addition of Sam A to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |